Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester
BJOG: An International Journal of Obstetrics & Gynaecology · 2024-11 · 131 (12) · 1715-1724
DOI: 10.1111/1471-0528.17897 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 02.07.2024. Verfasst von Xiaoxia Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai General Hospital of Nanjing Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Blood Glucose, Fasting, Pregnancy Trimester, Third. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Research Foundation of The Affiliated Taizhou People's Hospital of Nanjing Medical University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To investigate the positive rate of late‐onset gestational diabetes mellitus (GDM) by additional fasting blood glucose (FBG) screening at 32–34 gestational weeks (GW) and analyse the perinatal outcomes of late‐onset GDM after standard treatment.
Design
An Prospective cohort study.
Setting
Single centre in China. Population 1130 singleton pregnancies with negative GDM screening in their first and second trimester.
Methods
Additional FBG testing was performed at 32–34 GW. Pregnancies with FBG ≥5.1 mmol/L were diagnosed as GDM and received standardized treatment. Perinatal outcomes were collected and compared. Main Outcome Measures Diagnosis of late‐onset GDM, obstetric and neonatal outcomes.
Results
6.3% (71/1130) of participants had FBG values ≥5.1 mmol/L and were diagnosed with late‐onset GDM. Sixty‐five (91.5%) were treated by dietary therapy and 6 (8.5%) by insulin therapy. The perinatal outcomes of full‐term delivery were compared. The incidence of macrosomia (22.7% vs. 5.1%, adjusted odds ratio (aOR) 5.51, 95% confidence interval (CI) 1.83–16.61, p = 0.002) and NICU transferring (18.3% vs. 10.1%, aOR 1.94, 95% CI 1.01–3.74, p = 0.046) was significantly higher in late‐onset GDM group than that in FBG
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
- The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
ORCID-Profile: Xiaoxia Tang
Förderung
- Research Foundation of The Affiliated Taizhou People's Hospital of Nanjing Medical University
Zitieren
APA
Tang, X., Wei, J., Wu, S., & Wu, S. (2024). Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester. BJOG: An International Journal of Obstetrics & Gynaecology, 131(12), 1715-1724. https://doi.org/10.1111/1471-0528.17897
Vancouver
Tang X, Wei J, Wu S, Wu S. Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester. BJOG: An International Journal of Obstetrics & Gynaecology. 2024;131(12):1715-1724. doi:10.1111/1471-0528.17897
BibTeX
@article{Tang2024,
author = {Tang, Xiaoxia and Wei, Jin and Wu, Shaohua and Wu, Sufang},
title = {Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
volume = {131},
number = {12},
pages = {1715--1724},
doi = {10.1111/1471-0528.17897}
}
EUVIMED